Diary - News
All news Biom'Up completes the first of its financing operations for a total amount of more than €40 million
Saint-Priest, France, February 20, 2018 – 7.00 a.m. Paris time – Biom’Up (the “Company”), a specialist in surgical hemostasis, announces today the success of its capital increase without preferential subscription rights for shareholders by means of a public offering and with a priority subscription period, as of right only, for existing shareholders (the “Offering”), in a total amount (including additional paid-in capital) of €16 million. Athyrium Capital Management (“Athyrium”) has confirmed it is participating in the Offering and efforts are underway to finalize the €25 million bond issue (the “Bond Issue”) with stock warrants, the size of which may subsequently be increased to €35 million.